Zoetis Inc., an animal health company announced that Solensia, its treatment of osteoarthritis, has been granted marketing authorization from the European Commission. Specifically, Zoetis’ (ZTS) Solensia...
Vir Biotechnology and GlaxoSmithKline expanded a collaboration to develop strategies against COVID-19 to include work into new treatments for influenza and other respiratory viruses.
The temporary suspensions affect the Phase I/II HGB-206 trial, an ongoing, open-label study designed to evaluate the efficacy and safety of LentiGlobin gene therapy for sickle...
Psychedelics use is on the rise and it's partly due to a wellbeing rebrand.
Roche’s Italian subsidiary has joined forces with digital health startup PatchAi to roll out an app that aims The post Roche and PatchAi partner on digital...
Novavax and SK Group's vaccine subsidiary extended their collaboration and license agreement for the manufacturing of an additional 40 million doses of its COVID-19 vaccine for...
COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? The post 4 principles for the future of...
AstraZeneca announced yesterday that the World Health Organization (WHO) has granted an Emergency Use Listing (EUL) for its COVID-19 vaccine. The authorization permits the global use...
The U.S. Food and Drug Administration approved Pfizer Inc.'s supplemental Biologics License Application for Panzyga to treat adult patients with a rare neurological disease of the...
G1 Therapeutics announced that the US Food and Drug Administration (FDA) has approved its COSELA drug as a first-of-its-kind treatment for patients with extensive-stage small cell...
AI chatbots can provide mental health support for people who are isolated during the COVID-19 pandemic.
Shares of Illumina slipped 1.8% in Friday's pre-market trading despite the gene sequencing company announcing fourth quarter earnings results that beat analysts’ expectations. Earnings per share...
Regeneron announced that the US Food and Drug Administration (FDA) has approved its Evkeeza antibody as a first-of-its-kind treatment for adult and pediatric patients with extremely...
Orexo will start a new study of its modia app – used to treat people with opioid use The post Orexo eyes real-world testing of its...
Credit: Mor M, et al., 2021, PLOS Pathogens, CCBY 4.0 (https://creativecommons.org/licenses/by/4.0/) The majority of the population can produce neutralizing antibodies against severe acute respiratory syndrome coronavirus...
Tuesday was a good day for investors of Heat Biologics (HTBX). Shares blasted off by 50%, after the biotech company announced positive interim data for its...
The U.S. Food and Drug Administration granted Emergency Use Authorization (EUA) to a combination of Eli Lilly and AbCellera’s monoclonal antibody bamlanivimab and the Lilly antibody etesevimab...
The FDA has granted an emergency license for Eli Lilly’s COVID-19 antibody combination therapy, to reduce chances of severe COVID-19
A new EU-funded project called In Silico World aims to encourage the use of simulation for drug and The post EU-funded project encourages use of simulation...
Covid-19’s impact has been felt across most industries. H.C. Wainwright analyst Ram Selvaraju cites the pandemic as the reason behind lowered sales projections for Rockwell Medical...
Heat Biologics shares spiked 77% as the biopharma company reported positive interim data from the Phase 2 trial of its lung cancer treatment. The Phase 2...
An international trial led by US experts is to begin testing AstraZeneca’s long-acting antibody combination therapy
MUSC Hollings Cancer Center researchers join nationwide study to examine long-term outcomes of cancer patients diagnosed with COVID-19 Credit: MUSC Hollings Cancer Center Researchers at MUSC...
The U.S. Food and Drug Administration approved Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel; liso-cel) for adults with relapsed or refractory large B-Cell lymphoma after two or more...
I never dreamed this would be possible. Of course, so many things are possible today that I thought were impossible that I’m almost embarrassed to admit...
A therapeutic approach to restore the effectiveness of immune cells Credit: INRS Prompted by the need to improve conventional treatments for people infected with the human...
Bristol Myers Squibb announced on Feb. 5 that the US Food and Drug Administration (FDA) has approved its lymphoma drug, Breyanzi, a CAR-T (chimeric antigen receptor...
California-based Amgen is in the process of eliminating hundreds of U.S. jobs, the majority of which are centered on the company’s sales team, according to a...
Roche announced in the company's earnings report that the Swiss pharma giant is terminating studies of several mid-stage and late-stage assets, including two late-stage breast cancer programs.
Speaking with GEN last month, a Jazz executive said the company is moving toward expanding in neuroscience beyond sleep indications, through a mix of multiple indications...